Sanofi settles lawsuit with former Genzyme shareholders

Sanofi has agreed to a $315 million payout in an aging lawsuit alleging that the drugmaker failed to use " diligent efforts " to advance development of a former Genezyme multiple sclerosis drug that would have resulted in payouts to shareholders.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news